Connection

Thomas Efferth to Breast Neoplasms

This is a "connection" page, showing publications Thomas Efferth has written about Breast Neoplasms.
Connection Strength

0.452
  1. Ginkgolic acids inhibit migration in breast cancer cells by inhibition of NEMO sumoylation and NF-?B activity. Oncotarget. 2017 May 23; 8(21):35103-35115.
    View in: PubMed
    Score: 0.187
  2. Cajanol, a novel anticancer agent from Pigeonpea [Cajanus cajan (L.) Millsp.] roots, induces apoptosis in human breast cancer cells through a ROS-mediated mitochondrial pathway. Chem Biol Interact. 2010 Oct 06; 188(1):151-60.
    View in: PubMed
    Score: 0.117
  3. Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2). Phytomedicine. 2019 Feb 15; 54:140-148.
    View in: PubMed
    Score: 0.051
  4. Cytotoxic flavonoids from two Lonchocarpus species. Nat Prod Res. 2019 Sep; 33(18):2609-2617.
    View in: PubMed
    Score: 0.050
  5. Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2). Breast Cancer Res Treat. 2017 Jul; 164(2):359-369.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.